Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure

Cancer Chemotherapy and Pharmacology

Volumn 47, Issue 6, 2001, Pages 537-540

  Van Den Bongard, H J G Desirée ^a   Mathôt, Ron A A ^a   Boogerd, Willem ^a   Schornagel, Jan H ^b   Soesan, Marcel ^a   Schellens, Jan H M ^b   Beijnen, Jos H ^a,b  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Acute renal failure; High dose methotrexate; Leucovorin; Thymidine; Toxicity

Indexed keywords

ANTIBIOTIC AGENT; CYTARABINE; DIURETIC AGENT; FOLINIC ACID; FUROSEMIDE; IMIPENEM; METHOTREXATE; PHENYTOIN; THYMIDINE;

ACUTE KIDNEY FAILURE; ADULT; ANEMIA; ARTICLE; BRAIN LYMPHOMA; BRAIN TUMOR; CANCER CHEMOTHERAPY; CASE REPORT; CONJUNCTIVITIS; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG MEGADOSE; HEMODIALYSIS; HEMOPERFUSION; HUMAN; LYMPHOMA; MUCOSA INFLAMMATION; NEPHROTOXICITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN NEOPLASMS; DRUG THERAPY, COMBINATION; HUMANS; KIDNEY FAILURE, ACUTE; LEUCOVORIN; LYMPHOMA; METHOTREXATE; MIDDLE AGED; THYMIDINE;

EID: 0035024216     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800000269     Document Type: Article

References (24)

1. 1. Abelson HT, Fosburg MT, Beardsley PG, Goorin AM, Gorka C, Link M, Link D (1983) Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. J Clin Oncol 1:208
2. 2. Bertino JR (1977) "Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment. Semin Oncol 4:203
3. 3. Crom W (1998) Methotrexate and other antifolates. In: Grochow LB, Ames MM (eds) A clinician's guide to chemotherapy pharmacokinetics and pharmacodynamics. Williams and Wilkins, Baltimore, p 311
4. 2 rescue after high-dose methotrexate. J Clin Oncol 14:2145
5. 5. Decker DA, Edmonson JH, Gilchrist GS, Kovach JS, Offord JR, Taylor WF (1981) High-dose methotrexate with a safe rescue program. Oncology 38:262
6. 6. Flombaum CD, Meyers PA (1999) High-dose leucovorin as sole therapy for methotrexate toxicity. J Clin Oncol 17:1589
7. 7. Grem JL, King SA, Sorensen JM, Christian MC (1991) Clinical use of thymidine as a rescue agent from methotrexate toxicity. Invest New Drugs 9:281
8. 8. Grimes DJ, Bowles MR, Buttsworth JA, Thomson DB, Ravenscroft PJ, Nixon PF, Whiting RF, Pond SM (1990) Survival after unexpected high serum methotrexate concentrations in a patient with osteogenic sarcoma. Drug Safety 5:447
9. 9. Howell SB, Blair HE, Uren J, Frei E (1978) Hemodialysis and enzymatic cleavage of methotrexate in man. Eur J Cancer 14:787
10. 10. Howell SB, Ensminger WD, Krishan A, Frei E (1978). Thymidine rescue of high-dose methotrexate in humans. Cancer Res 38:325
11. 11. Howell SB, Krishan A, Frei E (1979) Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high-dose methotrexate. Cancer Res 39:1315
12. 2 rescue in delayed methotrexate-elimination due to renal failure. Pediatr Hematol Oncol 12:521
13. 13. Jambou P, Levraut J, Favier C, Ichai C, Milano G, Grimaud D (1995) Removal of methotrexate by continuous venovenous hemodiafiltration. Contrib Nephrol 116:48
14. 14. Kepka L, De Lassence A, Ribrag V, Gachot B, Blot F, Theodore C, Bonnay M, Korenbaum D, Nitenberg G (1998) Successful rescue in a patient with high dose methotrexateinduced nephrotoxicity and acute renal failure. Leuk Lymphoma 29:205
15. 15. Molina R, Fabian C, Cowley B (1987) Use of charcoal hemoperfusion with sequential hemodialysis to reduce serum methotrexate levels in a patient with acute renal insufficiency. Am J Med 82:350
16. 16. Powis G (1982) Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs. Cancer Treat Rev 9:85
17. 17. Relling MV, Stapleton BF, Ochs J, Jones DP, Meyer W, Wainer IW, Crom WR, McKay CP, Evans WE (1988) Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusion. Cancer 62:884
18. 18. Relling MV, Fairclough D, Ayers D, Crom WR, Rodman JH, Pui C-H, Evans WE (1994) Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J Clin Oncol 12:1667
19. 19. Schornagel JH, McVie JG (1983) The clinical pharmacology of methotrexate. Cancer Treat Rev 10:53
20. 20. Wall SM, Johansen MJ, Molony DA, DuBose TD, Jaffe N, Madden T (1996) Effective clearance of methotrexate using high-flux hemodialysis membranes. Am J Kidney Dis 28:846
21. 2 rescue in a patient with high-dose methotrexate-induced nephrotoxicity. Cancer 76:521
22. 2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction. J Clin Oncol 15:2125
23. 23. Wolfrom C, Hepp R, Hartmann R, Breithaupt H, Henze G (1990) Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue. Eur J Clin Pharmacol 39:377
24. 2 rescue in delayed methotrexate elimination due to renal failure. Pediatr Hematol Oncol 12:471